Petros Pharmaceuticals, Inc. (PTPI)
OTCMKTS · Delayed Price · Currency is USD
0.0083
+0.0004 (5.00%)
At close: Jan 23, 2026

Petros Pharmaceuticals Revenue

Petros Pharmaceuticals had revenue of $5.11M in the twelve months ending September 30, 2025. In the year 2024, Petros Pharmaceuticals had annual revenue of $5.11M, down -12.20%.

Revenue
5.11M
Revenue Growth
-12.20%
P/S Ratio
0.07
Revenue / Employee
284.00K
Employees
18
Market Cap
351.69K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.11M-710.35K-12.20%
Dec 31, 20235.82M-169.67K-2.83%
Dec 31, 20225.99M-1.82M-23.29%
Dec 31, 20217.81M-1.75M-18.29%
Dec 31, 20209.56M-6.02M-38.63%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Ecofibre17.56M
Cannabis Strategic Ventures14.60M
Endexx4.64M
Fifty 1 Labs4.08M
Stemtech3.73M
Demand Brands165.00K
Neutra66.07K
ViaDerma44.69K
Revenue Rankings